CXD90™ is
scientifically validated

Many clinical studies demonstrate the anti-inflammatory and/or anti-spasmodic properties of some of the ingredients used in CXD90™. Some of the studies are shown below.

1. Curcumin significantly lowers IBS prevalence by 60%

    Randomised, partially-blinded, two dose pilot study of 105 IBS subjects


Section Reference:
Bundy R. et al. (2004) Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: a pilot study. Journal of Alternative and Complementary Medicine, 10(6); 1015-1018.

Previous | Next

Copyright © 2013 by InQpharm Group. All rights reserved. Last updated: July 2013 | ID: MC/TM/EN/13/002
CXD90 and InQpharm are trademarks of the InQpharm group of companies.